Q3 2026
Released Nov 5, 2026, before the open
10-Q filed Nov 5, 2026, 36 days after period end · 0001628280-26-070521
What the release said
On November 5, 2026, Zai Lab Limited issued a press release announcing its financial results for the third quarter of 2026.
Total revenue was $108.2 million in the third quarter of 2026, compared to $116.1 million for the same period in 2025.¶2
Net loss was $46.1 million in the third quarter of 2026, or $0.04 per ordinary share, compared to a net loss of $36.0 million, or $0.03 per ordinary share, in 2025.¶3
On October 22, 2026, the Company agreed to sell 11,340,000 ADSs at $22.04 per ADS in a private placement that closed on October 27, 2026, with net proceeds of approximately $241.2 million.¶4
Cash and cash equivalents, current restricted cash, and short-term investments totaled $659.7 million as of September 30, 2026, compared to $717.5 million as of June 30, 2026.¶5
Zoci plus atezolizumab achieved a confirmed objective response rate of 81.8% and an estimated 6-month PFS rate of 81.9% among 33 efficacy evaluable patients, and Zai Lab is advancing it into a global Phase 3 study.¶6
- Total revenue
- $108.2 million Third quarter of 2026, compared to $116.1 million for the same period in 2025¶2
- Net loss
- $46.1 million Third quarter of 2026, compared to $36.0 million for the same period in 2025¶3
- Loss per ordinary share
- $0.04 Third quarter of 2026, compared to $0.03 for the same period in 2025¶3
- Cash, restricted cash and short-term investments
- $659.7 million As of September 30, 2026, compared to $717.5 million as of June 30, 2026¶5
- Inventory write-downs
- $13.6 million Cited as the primary driver of the increase in net loss in 2026¶3
Same quarter
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $107.65M | $115.36M | $101.85M | $69.23M |
| Net Income | -$46.14M | -$35.96M | -$41.67M | -$69.15M |
| EPS Diluted | -$0.04 | -$0.03 | -$0.04 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR